Current Aphria News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights Tilray (NASDAQ:TLRY) has given investors plenty to cheer about so far this year. Its share price has more than quadrupled partly due to excitement about the pending merger with Aphria (NASDAQ:APHA). However, Tilray's business performance hasn't been so great in recent quarte...

Published: Dec 30, 2020 at 6:56AM On Dec. 16, Tilray (NASDAQ:TLRY) announced plans to merge in an all stock transaction that would create a company with pro forma combined revenues of almost $685 million, pushing past the sector's current leader, The specifics of the deal are as follows: Current Aphria shareholders will receive .8381 shares of the "new" entity (to operate under the Tilray name and current ticker symbol) for each Aphria common share, while Tilray shareholders will retain all their current share holdings. Post-merger, Aphria shareholders will control 62% o...